Contraception in patients with a history of cancer: skin, gastrointestinal, hematological, and endocrine cancers (Part II)
- Authors: Yakushevskaya O.V.1, Yureneva S.V.1, Ashrafyan L.A.1, Babaeva N.A.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 12 (2022)
- Pages: 50-56
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/250295
- DOI: https://doi.org/10.18565/aig.2022.187
- ID: 250295
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Oksana V. Yakushevskaya
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: aluckyone777@gmail.com
PhD, Researcher at the Department of Gynecological Endocrinology
Svetlana V. Yureneva
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: syureneva@gmail.com
Dr. Med. Sci., Deputy Director in Science, Institute of Oncology and Mammology
Levon A. Ashrafyan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: levaa2004@yahoo.com
Academician of the RAS, Dr. Med. Sci., Professor, Director of the Institute of Oncology and Mammology
Nataliya A. Babaeva
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: natbabaeva@yandex.ru
Dr. Med. Sci., Oncologist, Oncological Department of Surgical Methods of Treatment, Leading Researcher, Institute of Oncogynecology and Mammology
References
- Cagnacci A., Ramirez I., Bitzer J., Gompel A. Contraception in cancer survivors - an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers. Eur. J. Contracept. Rep. Health Care. 2019; 24(4): 299-304. https://dx.doi.org/10.1080/13625187.2019.1604947.
- Global Cancer Observatory. 2018. All cancers. Available at: http://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancersfact-sheet.pdf Accessed 15 March 2019.
- Da Silva F.C., Wernhoff P., Dominguez-Barrera C., Dominguez-Valentin M. Update on hereditary colorectal cancer. Anticancer Res. 2016; 36(9): 4399-405. https://dx.doi.org/10.21873/anticanres.10983.
- Syngal S., Brand R.E., Church J.M., Giardiello F.M., Hampel H.L., Burt R.W.; American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 2015; 110(2): 223-62. https://dx.doi.org/10.1038/ajg.2014.435.
- Carethers J.M., Stoffel E.M. Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J. Gastroenterol. 2015; 21(31): 9253-61. https://dx.doi.org/10.3748/wjg.v21.i31.9253.
- Cercek A., Siegel C.L., Capanu M. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin. Colorectal Cancer. 2013; 12(3): 163-7. https://dx.doi.org/10.1016/j.clcc.2013.04.007.
- Wan J., Gai Y., Li G., Tao Z., Zhang Z. Incidence of chemotherapyand chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin. Colorectal Cancer. 2015; 14(1): 31-4. https://dx.doi.org/10.1016/j.clcc.2014.09.012.
- Cibula D., Gompel A., Mueck A.O., La Vecchia C., Hannaford P.C., Skouby S.O. et al. Hormonal contraception and risk of cancer. Hum. Reprod. Update. 2010; 16(6): 631-50. https://dx.doi.org/10.1093/humupd/dmq022.
- Lu K.H., Loose D.S., Yates M.S., Nogueras-Gonzalez G.M., Munsell M.F., Chen L.M. et al. Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus Depo-Provera for prevention of endometrial cancer in women with Lynch syndrome. Cancer Prev. Res. (Phila). 2013; 6(8): 774-81. https://dx.doi.org/10.1158/1940-6207.CAPR-13-0020.
- Sangiovanni A., Colombo M. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2016; 36(Suppl. 1): 124-9. https://dx.doi.org/10.1111/liv.13028.
- Maheshwari S., Sarraj A. Oral contraception and the risk of hepatocellular carcinoma. J. Hepatol. 2007; 47(4): 506-13. https://dx.doi.org/10.1016/j.jhep.2007.03.015.
- Ter as L.R., DeSantis C.E., Cerhan J.R., Morton L.M., Jemal A., Flowers C.R. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J. Clin. 2016; 66(6): 443-59. https://dx.doi.org/10.3322/caac.21357.
- Arber D.A., Orazi A., Hasserjian R., Thiele J., Borowitz M.J., Le Beau M.M. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20): 2391-405. https://dx.doi.org/10.1182/blood-2016-03-643544.
- Chen H., Xiao L., Li J. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women (Review). Cochrane Database Syst. Rev. 2019; (3): CD008018. https://dx.doi.org/10.1002/14651858. CD008018.pub3.
- Elgindy E., Sibai H., Abdelghani A., Mostafa M. Protecting ovaries during chemotherapy through gonad suppression: a systematic review and metaanalysis. Obstet. Gynecol. 2015; 126(1): 187-95. https://dx.doi.org/10.1097/AOG.0000000000000905.
- Oktay K., Harvey B.E., Partridge A.H., Quinn G.P., Reinecke J., Taylor H.S. et al. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. J. Clin. Oncol. 2018; 36(19): 1994-2001. https://dx.doi.org/10.1200/JCO.2018.78.1914.
- Kane E.V., Roman E., Becker N., Bernstein L., Boffetta P., Bracci P.M. Menstrual and reproductive factors, and hormonal eontraception use: аssociations with non-Hodgkin lymphoma in a pooled analysis of Inter Lymph case-control studies. Ann. Oncol. 2012; 23(9): 2362-74. https://dx.doi.org/10.1093/annonc/mds171.
- Costas L., Lambert B.H., Birmann B.M., Moysich K.B., De Roos A.J., Hofmann J.N. et al. A pooled analysis of reproductive factors, exogenous hormone use, and risk of multiple myeloma among women in the International Multiple Myeloma Consortium. Cancer Epidemiol. Biomarkers Prev. 2016; 25(1): 217-21. https://dx.doi.org/10.1158/1055-9965.EPI-15-0953.
- Roman E., Smith A., Appleton S., Crouch S., Kelly R., Kinsey S. et al. Cancer Epidemiol. 2016; 42: 186-98. https://dx.doi.org/10.1016/j.canep.2016.03.011.
- Yaish I., Azem F., Gutfeld O., Silman Z., Serebro M., Sharon O. et al. A single radioactive iodine treatment has a deleterious effect on ovarian reserve in women with thyroid cancer: results of a prospective pilot study. Thyroid. 2018; 28(4): 522-7. https://dx.doi.org/10.1089/thy.2017.0442.
- Evranos B., Faki S., Polat S.B., Bestepe N., Ersoy R., Cakir B. et al. Effects of radioactive iodine therapy on ovarian reserve: a prospective pilot study. Thyroid. 2018; 28(12): 1702-7. https://dx.doi.org/10.1089/thy.2018.0129.
- Braganza M.Z., de Gonzalez A.B., Schonfeld S.J., Wentzensen N., Brenner A.V., Kitahara C.M. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev. Res. (Phila). 2014; 7(4): 418-25. https://dx.doi.org/10.1158/1940-6207.CAPR-13-0367.
- Xhaard C., Rubino C., Clero E., Maillard S., Ren Y., Borson-Chazot F. et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am. J. Epidemiol. 2014; 180(10): 1007-17. https://dx.doi.org/10.1093/aje/kwu220.
- Tang B., Lv J., Li Y., Yuan S., Wang Z., He S. Relationship between female hormonal and menstrual factors and pancreatic cancer: a metaanalysis of observational studies. Medicine (Baltimore). 2015; 94(4): e17. https://dx.doi.org/10.1097/MD.0000000000000177.
- Lee E., Horn-Ross P.L., Rull R.P., Neuhausen S.L., Anton-Culver H., Ursin G. et al. Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am. J. Epidemiol. 2013; 178(9): 1403-13. https://dx.doi.10.1093/aje/kwt154.
- Fassnacht M., Dekkers O.M. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2018; 179(4): G1-46. https://dx.doi.org/10.1530/EJE-18-0608.
Supplementary files
![](/img/style/loading.gif)